And adverse event reporting increased by more than 2,000 notifications, according to TGA’s latest stats Key observations for 2016-17 compared with 2015-16, provided by the TGA are as follows: 1. The number of new ingredients approved for use in listed medicines significantly increased to 79 in 2016-17, compared with 18 in 2015-16. 2. Adverse event reporting
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.